Varex Imaging Corp (VREX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $768.59M
Last updated: Nov 17, 2026 at 11:05 AM ET
Varex Imaging Corp (VREX) Earnings: Report Dates and Results
Varex Imaging (VREX) is expected to report earnings on Nov 24, 2026. In the quarter ended Jun 30, 2026, Varex Imaging reported EPS of $0.31, above the $0.22 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
VREX has an expected report date of Nov 24, 2026. Analysts' consensus for the quarter ended Sep 30, 2026 is 16.2% below the $0.37 reported for the quarter ended Sep 30, 2025.
VREX Earnings Call
The latest VREX earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 39 quarters below that had an estimate, VREX beat 23, missed 13 and matched 3. Revenue for the quarter ended Jun 30, 2026 was $210.50M, up 3.7% from $203.00M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | $0.31 | $0.22 | $0.15 - $0.23 | +40.91% | Beat | +72.2% | 5 | 0 up, 2 down | Aug 10, 2026 | $210.50M |
| Mar 31, 2026 | $0.21 | $0.21 | $0.20 - $0.22 | 0.00% | In line | -19.2% | 4 | N/A | May 7, 2026 | $216.00M |
| Dec 31, 2025 | $0.19 | $0.13 | $0.10 - $0.18 | +46.15% | Beat | +171.4% | 5 | 0 up, 1 down | Feb 10, 2026 | $209.60M |
| Sep 30, 2025 | $0.37 | $0.18 | $0.15 - $0.20 | +105.56% | Beat | +94.7% | 4 | 3 up, 0 down | Nov 18, 2025 | $228.90M |
| Jun 30, 2025 | $0.18 | $0.04 | $0.02 - $0.05 | +350.00% | Beat | +28.6% | 4 | 0 up, 4 down | Aug 7, 2025 | $203.00M |
| Mar 31, 2025 | $0.26 | $0.14 | $0.13 - $0.14 | +85.71% | Beat | +62.5% | 4 | 1 up, 0 down | May 8, 2025 | $212.90M |
| Dec 31, 2024 | $0.07 | $0.04 | $0.02 - $0.05 | +75.00% | Beat | +16.7% | 3 | 1 up, 0 down | Feb 6, 2025 | $199.80M |
| Sep 30, 2024 | $0.19 | $0.09 | $0.07 - $0.12 | +111.11% | Beat | -57.8% | 4 | 0 up, 1 down | Nov 19, 2024 | $205.70M |
| Jun 30, 2024 | $0.14 | $0.19 | $0.18 - $0.21 | -26.32% | Miss | -62.2% | 3 | 0 up, 0 down | Aug 1, 2024 | $209.10M |
| Mar 31, 2024 | $0.16 | $0.21 | $0.19 - $0.23 | -23.81% | Miss | -38.5% | 3 | 0 up, 0 down | May 2, 2024 | $206.20M |
| Dec 31, 2023 | $0.06 | $0.11 | $0.06 - $0.15 | -45.45% | Miss | -71.4% | 3 | 0 up, 0 down | Feb 6, 2024 | $190.00M |
| Sep 30, 2023 | $0.45 | $0.35 | $0.33 - $0.37 | +28.57% | Beat | +7.1% | 3 | 0 up, 0 down | Nov 14, 2023 | $227.40M |
| Jun 30, 2023 | $0.37 | $0.32 | $0.28 - $0.34 | +15.63% | Beat | 0.0% | 3 | 0 up, 0 down | Aug 1, 2023 | $232.20M |
| Mar 31, 2023 | $0.26 | $0.18 | $0.15 - $0.23 | +44.44% | Beat | -29.7% | 3 | 0 up, 0 down | May 2, 2023 | $228.20M |
| Dec 31, 2022 | $0.21 | $0.19 | $0.17 - $0.21 | +10.53% | Beat | -16.0% | 3 | 0 up, 0 down | Jan 31, 2023 | $205.60M |
| Sep 30, 2022 | $0.42 | $0.36 | $0.35 - $0.37 | +16.67% | Beat | -6.7% | 3 | 0 up, 0 down | Nov 15, 2022 | $231.40M |
| Jun 30, 2022 | $0.37 | $0.25 | $0.24 - $0.25 | +48.00% | Beat | -7.5% | 2 | 0 up, 0 down | Aug 2, 2022 | $214.50M |
| Mar 31, 2022 | $0.37 | $0.23 | $0.20 - $0.26 | +60.87% | Beat | +5.7% | 2 | 0 up, 0 down | May 3, 2022 | $214.70M |
| Dec 31, 2021 | $0.25 | $0.28 | $0.25 - $0.31 | -10.71% | Miss | +212.5% | 2 | 0 up, 0 down | Feb 8, 2022 | $198.80M |
| Sep 30, 2021 | $0.45 | $0.37 | $0.35 - $0.38 | +21.62% | Beat | N/A | 3 | 0 up, 0 down | Nov 16, 2021 | $226.30M |
| Jun 30, 2021 | $0.40 | $0.27 | $0.25 - $0.29 | +48.15% | Beat | N/A | 3 | N/A | Aug 3, 2021 | $211.20M |
| Mar 31, 2021 | $0.35 | $0.16 | $0.15 - $0.18 | +118.75% | Beat | +191.7% | 4 | N/A | May 4, 2021 | $203.50M |
| Dec 31, 2020 | $0.08 | -$0.03 | -$0.06 - $0.03 | +366.67% | Beat | -61.9% | 4 | N/A | Feb 4, 2021 | $177.10M |
| Sep 30, 2020 | -$0.04 | -$0.10 | -$0.15 - -$0.04 | +60.00% | Beat | -108.7% | 4 | N/A | Nov 17, 2020 | $170.00M |
| Jun 30, 2020 | -$0.20 | $0.07 | -$0.17 - $0.08 | -385.71% | Miss | -183.3% | 4 | N/A | Aug 12, 2020 | $171.20M |
| Mar 31, 2020 | $0.12 | $0.35 | $0.33 - $0.36 | -65.71% | Miss | -64.7% | 4 | N/A | May 12, 2020 | $197.00M |
| Dec 31, 2019 | $0.21 | $0.26 | $0.19 - $0.30 | -19.23% | Miss | -19.2% | 3 | N/A | Feb 11, 2020 | $200.10M |
| Sep 30, 2019 | $0.46 | $0.44 | $0.41 - $0.49 | +4.55% | Beat | +58.6% | 4 | N/A | Nov 12, 2019 | $202.40M |
| Jun 30, 2019 | $0.24 | $0.34 | $0.27 - $0.39 | -29.41% | Miss | -29.4% | 4 | N/A | Aug 6, 2019 | $196.70M |
| Mar 31, 2019 | $0.34 | $0.34 | $0.28 - $0.38 | 0.00% | In line | -24.4% | 4 | N/A | May 7, 2019 | $195.80M |
| Dec 31, 2018 | $0.26 | $0.25 | $0.14 - $0.27 | +4.00% | Beat | +13.0% | 4 | N/A | Feb 5, 2019 | $185.70M |
| Sep 30, 2018 | $0.29 | $0.30 | N/A | -3.33% | Miss | -50.8% | N/A | N/A | Nov 13, 2018 | $204.80M |
| Jun 30, 2018 | $0.34 | $0.51 | $0.47 - $0.57 | -33.33% | Miss | -22.7% | 4 | N/A | Aug 2, 2018 | $191.20M |
| Mar 31, 2018 | $0.45 | $0.45 | $0.38 - $0.50 | 0.00% | In line | +12.5% | 4 | N/A | May 3, 2018 | $201.20M |
| Dec 31, 2017 | $0.23 | $0.41 | $0.39 - $0.41 | -43.90% | Miss | -23.3% | 2 | N/A | Feb 1, 2018 | $176.20M |
| Sep 30, 2017 | $0.59 | $0.54 | N/A | +9.26% | Beat | 0.0% | 3 | N/A | Nov 9, 2017 | $215.80M |
| Jun 30, 2017 | $0.44 | $0.46 | $0.40 - $0.51 | -4.35% | Miss | N/A | 2 | N/A | Aug 3, 2017 | $170.10M |
| Mar 31, 2017 | $0.40 | $0.38 | N/A | +5.26% | Beat | N/A | 2 | N/A | May 4, 2017 | $154.80M |
| Dec 31, 2016 | $0.30 | $0.43 | N/A | -30.23% | Miss | N/A | 2 | N/A | Jan 20, 2017 | $157.40M |
| Sep 30, 2016 | $0.59 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 30, 2016 | $172.10M |
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was $0.71, down 19.3% from the year before. It was $1.73 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | $0.71 | -19.3% |
| Sep 30, 2025 | $0.88 | +60.0% |
| Sep 30, 2024 | $0.55 | -57.4% |
| Sep 30, 2023 | $1.29 | -8.5% |
| Sep 30, 2022 | $1.41 | +10.2% |
| Sep 30, 2021 | $1.28 | +1322.2% |
| Sep 30, 2020 | $0.09 | -93.1% |
| Sep 30, 2019 | $1.30 | N/A |
| Sep 30, 2018 | $1.31 | -24.3% |
| Sep 30, 2017 | $1.73 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 6,300 words across 8 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 6,274 | 8 | |
| 2026Q1 | Mar 31, 2026 | 6,039 | 8 | |
| 2025Q4 | Dec 31, 2025 | 6,804 | 8 | |
| 2025Q3 | Sep 30, 2025 | 5,959 | 9 | |
| 2025Q2 | Jun 30, 2025 | 7,988 | 8 | |
| 2025Q1 | Mar 31, 2025 | 7,559 | 9 | |
| 2024Q4 | Dec 31, 2024 | 6,971 | 8 | |
| 2024Q3 | Sep 30, 2024 | 3,450 | 7 |
2026Q2 Earnings Call
Opening remarks
Christopher Belfiore Director of Investor Relations Good afternoon, and welcome to Varex Imaging's Earnings Conference Call for the Second Quarter fiscal year 2026. With me today are Sunny Sanyal, our President and CEO; and Sam Maheshwari, our CFO. Please note that the live webcast of this conference call includes a supplemental slide presentation that can be accessed at Varex's website at vareximaging.com. The webcast and supplemental slide presentation will be archived on Varex's website. To simplify our discussion, unless otherwise stated, all references to the quarter are for the second quarter of fiscal year 2026 and to the year are for the fiscal year 2026. In addition, unless otherwise stated, quarterly comparisons are made year-over-year from the second quarter of fiscal year 2026 to the second quarter of fiscal year 2025. Finally, all references to the year are to the fiscal year and not the calendar year, unless otherwise stated. Please be advised that during this call, we will be making forward-looking statements, which are predictions or projections about future events. These statements are based on current information, expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated. Risks relating to our business are described in our quarterly earnings release and our filings with the SEC. Additional information concerning factors that could cause actual results to materially differ from those anticipated is contained in our SEC filings, including Item 1A, Risk Factors of our quarterly reports on Form 10-Q and our annual report on Form 10-K. The information in this discussion speaks as of today's date, and we assume no obligation to update or revise the forward-looking statements in this discussion. On today's call, we will discuss certain non-GAAP financial measures. Our non-GAAP measures are not presented in accordance with, nor are they a substitute for GAAP financial measures. We provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure in our earnings press release, which is posted on our website. I will now turn the call over to Sunny.
Sunny Sanyal President and CEO Thank you, Chris. Good afternoon, everyone, and thank you for joining us for our second quarter earnings call. I'm pleased to say that we delivered a solid second quarter in both Medical and Industrial while strengthening our capital structure and continuing to shift our business towards advanced imaging technologies and higher-growth industrial applications. Revenue for the quarter came in within the guidance range at $216 million. Non-GAAP gross margin was 34% and non-GAAP EPS was $0.21. I'd also like to highlight that during the quarter, we completed our debt refinancing activities, which resulted in the reduction of outstanding debt and a decrease in our annual interest expense.
Frequently Asked Questions About VREX
When is Varex Imaging's next earnings date?
Varex Imaging's next earnings report is expected for Nov 24, 2026.
Did VREX beat earnings estimates last quarter?
Yes. Varex Imaging reported EPS of $0.31 for the quarter ended Jun 30, 2026, above the $0.22 estimate, a 40.91% surprise.
What EPS do analysts expect from VREX next quarter?
The consensus EPS estimate for Varex Imaging for the quarter ended Sep 30, 2026 is $0.31 from 5 analysts, with estimates from $0.28 to $0.35.
How often does VREX beat earnings estimates?
Varex Imaging beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +101.81%.
VREX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts